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abstract
Polymorphisms in the gene encoding bone morphogenetic protein 15 (BMP15) have been associated with multiple ovulations in 
sheep. as BMP15 regulates inhibin expression in rodents, we assumed that the ovarian inhibin/activin system could mediate part of 
the effect of BMP15 mutations in the regulation of ovulation rate in sheep. To answer this question, we have studied the effects of two 
natural loss-of-function mutations of BMP15 on the expression of components of this system. The FecXR and the FecXGr mutations, 
when present respectively in Rasa aragonesa ewes at the heterozygous state and in Grivette ewes at the homozygous state, were 
associated with a twofold increase in ovulation rate. There were only small differences between mutant and wild-type ewes for mRNa 
expression of INHA, INHBA, ACVR1B, ACVR2A, FST or TGFBR3 in granulosa cells and inhibin a or activin a concentrations in 
follicular fluid. Moreover, the effects of mutations differed between breeds. In cultures of granulosa cells from wild-type ewes, 
BMP15, acting alone or in synergy with GDF9, stimulated INHA, INHBA and FST expression, but inhibited the expression of TGFBR3. 
activin a did not affect INHBA expression, but inhibited the expression of ACVR2A also. The complexity of the inhibin/activin 
system, including positive and antagonistic elements, and the differential regulation of these elements by BMP15 and activin can 
explain that the effects of BMP15 mutations differ when present in different genetic backgrounds. In conclusion, the ovarian inhibin/
activin system is unlikely to participate in the increase of ovulation rate associated with BMP15 mutations in sheep.
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Introduction
Increasing evidence support the involvement of 
cytokines belonging to the transforming growth factor 
beta (TGFβ) family in the control of ovulation number 
at each sexual cycle (ovulation rate) in adult females. 
In particular, the bone morphogenetic proteins BMP15 
(bone morphogenetic protein 15) and GDF9 (growth 
differentiation factor 9), known to be specifically 
expressed in the oocyte (McGrath  et  al. 1995, 
Dube et al. 1998), could play a key role in this process. 
In sheep, heterozygous carriers of various missense 
mutations affecting BMP15 or GDF9 or carriers of 
a partial loss-of-function mutation in their receptor 
BMPR1B, exhibit systematically increased ovulation 
rates and litter sizes (reviews: Montgomery  et  al. 
2001, Galloway  et  al. 2002, McNatty  et  al. 2003, 
Fabre et al. 2006, Persani et al. 2014). Polymorphisms 
in GDF9, BMPR1B and SMAD3 (encoding a BMP15/
GDF9 signaling factor) have also been shown to occur 
among human cohorts with a propensity for dizygotic 
twins (Palmer  et  al. 2006, Hoekstra  et  al.  2008, 
Luong  et  al.  2011, Mbarek  et  al.  2016), and the 
presence of non-synonymous substitutions in BMP15 or 
GDF9 genes has been recently associated with twinning 
in callitrichine primates (Harris  et  al. 2014). From a 
phylogenetic analysis comparing mono- and poly-
ovulating mammalian species, high variations have been 
observed in specific areas of BMP15 and GDF9, which 
are able to modify the biological activity of the proteins 
in poly-ovulating mammals (Monestier et al. 2014).
The mechanisms by which BMP15 and GDF9 
control the ovulation rate are not fully understood. 
BMP15, acting alone or in synergy with GDF9, can 
modulate follicle growth and maturation by controlling 
granulosa cell proliferation and their responsiveness 
to FSH (Otsuka  et al. 2000, 2001, Moore  et al. 2003, 
McNatty  et  al. 2005b, Moore & Shimasaki 2005). 
Recently, the anti-Müllerian hormone (AMH), another 
member of the TGFβ family known to importantly 
modulate FSH sensitivity (Durlinger et al. 2001, Visser 
& Themmen 2005, 2014, Knight & Glister 2006), has 
also been proposed to participate in this mechanism. 
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Indeed, BMP15 enhances the expression of AMH and its 
specific receptor AMHR2 in the granulosa cells of sheep 
antral follicles, and hyperprolific ewes carrying a loss-
of-function mutation in BMP15 or its receptor BMPR1B 
show respectively impaired expression of AMHR2 
or AMH (Estienne et al. 2015, Pierre et al. 2016). It is 
suggested that low BMP15 and low AMH signaling in 
follicles of these mutant ewes contribute to sensitizing 
granulosa cells to FSH, thereby promoting the selection 
and maintenance of follicles during the follicular phase, 
and thus enhancing the ovulation rate.
Inhibins and activins, other members of the TGFβ 
family, could also be involved in the mechanisms 
leading to multiple ovulations. Inhibins and activins are 
produced by the granulosa cells of growing follicles and 
known to act in an opposite way on their target cells. 
Activins are importantly implicated in follicular growth, 
acting in an intra-ovarian way by promoting granulosa 
cell proliferation, enhancing FSHR (follicle-stimulating 
hormone receptor) and CYP19A1 (cytochrome P450 
family 19 subfamily A member 1, also known as 
aromatase) expression, and inhibiting follicle atresia 
and luteinization, whereas inhibins oppose the activin 
signaling, thus modulating these processes (Knight et al. 
2012). Inhibins are secreted by the largest follicles during 
terminal follicular development and are important 
inhibitors of FSH secretion by pituitary gonadotrophs. 
In various animal species, immunization against inhibin 
induces multiple ovulations and an increase in pituitary 
secretion of FSH appears to be the main mechanism by 
which the growth of additional follicles is stimulated 
(Henderson et al. 1984, Forage et al. 1987, Hillard et al. 
1995, Drummond  et  al. 2004, Yan  et  al. 2015). 
However, immunization against inhibin is not always 
accompanied by the expected rise in plasma FSH, and 
intra-ovarian effects of neutralizing endogenous inhibin 
bioactivity might also be involved in the stimulation 
of follicular development (Tannetta  et  al. 1998). 
Interestingly, the specific intra-ovarian glycosylation 
of the inhibin alpha and beta A subunits is associated 
with multiple ovulations and high prolificacy in ewes 
carrying the FecLL, mutation which induces an ectopic 
expression of the B4GALNT2 (beta-1,4-N-acetyl-
galactosaminyl transferase 2) gene within the ovary 
(Drouilhet et al. 2013).
We assumed that the ovarian inhibin/activin system 
could mediate part of the effect of BMP15 mutations in 
the regulation of ovulation rate in sheep. This assumption 
is supported by the findings that BMP15 can activate 
in vitro the transcription of genes encoding inhibin 
subunits and follistatin (the specific activin-binding 
protein) in mouse granulosa cells (Li  et  al. 2009) and 
cooperates with GDF9 in enhancing immunoreactive 
inhibin production in rat granulosa cells (McNatty et al. 
2005a). To answer this question, we have analyzed the 
in vivo effects of two natural loss-of-function mutations 
of BMP15 in two ovine breeds on the expression of 
components of the inhibin/activin system in relationship 
with the hyperprolific phenotype of mutant ewes. We 
took into consideration various components of this 
system, including the INHA and INHBA subunits, the 
activin signaling receptors ACVR1B and ACVR2A and 
the known antagonists of activin, which are follistatin 
(FST) and the TGFβ type 3 receptor (TGFBR3, also known 
as betaglycan, a co-receptor of inhibin, able to block 
activin signaling) (Walton et al. 2012). In addition, we 
studied the acute in vitro effects of BMP15 on the mRNA 
expression of these components in ovine granulosa 
cells, in comparison with those of other factors of the 
TGFβ family such as BMP4, GDF9 and activin A.
Materials and methods
Animals
For in vivo expression studies, granulosa cells were recovered 
from hyperprolific ewes carrying mutations in the BMP15 
gene and their corresponding non-carrier ewes of the same 
breed. The BMP15W154NFsX55/FecXR mutation is a 17 bp deletion 
creating a premature stop codon in the BMP15 pro-region; it 
causes hyperprolificacy in the Spanish Rasa Aragonesa breed 
when the mutation is present in ewes at the heterozygous state 
and sterility when present at the homozygous state (Martinez-
Royo  et  al. 2008). The BMP15T317I/FecXGr mutation is a 
substitution of a threonine for an isoleucine, which affects the 
hydrophobicity of the protein and impairs its signaling activity; 
it causes hyperprolificacy in the French Grivette breed when 
the mutation is present at the heterozygous state and even more 
at the homozygous state (Demars  et  al. 2013). In this study, 
6 Rasa Aragonesa ewes heterozygous carriers of the FecXR 
mutation (R/+; ovulation rate = 1.89 ± 0.16), 6 Rasa Aragonesa 
non-carrier ewes (+/+; ovulation rate = 1.00), 5 Grivette ewes 
homozygous carriers of the FecXGr mutation (Gr/Gr; ovulation 
rate = 4.88 ± 0.55) and 5 Grivette non-carrier ewes (+/+; 
ovulation rate = 2.29 ± 0.20) were used after genotyping.
All animals were treated during their seasonal period 
of reproduction with intravaginal progestagen sponges 
(fluogestone acetate, 20 mg; Intervet, Angers, France) for 
14  days to synchronize estrus, before slaughtering of the 
ewes 36 h after sponge removal, corresponding to the 
follicular phase of the cycle. Ovaries from all genotypes 
were recovered in a local slaughterhouse at Zaragoza (Spain) 
and Toulouse (France), for the Rasa Aragonesa and Grivette 
breeds respectively. All procedures were approved by the 
Agricultural and Scientific Research Government Committees 
and local ethical committees (Approval numbers C37-175-2 
in Nouzilly, C31-429-01 in Toulouse and – CITA 2011-08 in 
Zaragoza) in accordance with the guidelines for Care and Use 
of Agricultural Animals in Agricultural Research and Teaching.
Collection and culture of granulosa cells
Collected ovaries were finely dissected to isolate all the antral 
follicles larger than 1 mm in diameter. For each animal, the 
follicles were then classified according to their size and 
genotype. For the evaluation of in vivo gene expression in 
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Rasa Aragonesa and Grivette ewes, two follicular classes 
were defined, small (1–3 mm) and large (larger than or equal 
to 5 mm) follicles, corresponding to follicle growth and 
dominance stages respectively. Follicular fluid and granulosa 
cells were recovered from small and large follicles as described 
(Estienne et al. 2015). For small follicles, follicular fluid and 
granulosa cells were pooled within animal. The volumes of 
follicular fluid recovered by follicular puncture from each 
animal were at least 50 µL for individual large follicles and 
5 µL for pooled small follicles. Follicular fluids and granulosa 
cells were stored at −80°C for further analysis.
For culture experiments, ovaries were recovered from 
ewes of various breeds wildtype at the two BMP15 loci after 
slaughtering in a local slaughterhouse at Nouzilly (France). 
Granulosa cells from 1 to 3 mm follicles were cultured in serum-
free conditions in McCoy’s 5a medium (Sigma) containing 
insulin (100 ng/mL) according to a previously described method 
(Campbell 1996). Cells were seeded at 105 viable cells/well in 
96-well plates with and without recombinant human BMP4, 
human BMP15, mouse GDF9 or human/mouse/rat Activin A 
(50 ng/mL each; R&D System Europe), each treatment being 
tested in 12 replicate wells. After 48 h of culture, cells were 
recovered using Accutase (Sigma), and then pooled according 
to treatment, centrifuged and cell pellets were stored at −80°C 
for further RNA extraction. In total, 15 independent culture 
experiments were performed.
RNA extraction and quantitative real-time PCR
Samples of granulosa cell recovered in vivo and after 
culture were analyzed for mRNA content of genes encoding 
components of the inhibin/activin system (INHA, INHBA, 
ACVR1B, ACVR2A, FST and TGFBR3). For in vivo gene 
expression studies, the stage of follicular maturation and 
health was assessed using classic markers of differentiation 
(CYP19A1) and atresia (IGFBP5) in ovine granulosa cells 
(Besnard  et  al. 1996, Logan  et  al. 2002). Total RNA was 
extracted with a Nucleospin RNA II kit (Macherey-Nagel, 
Hoerdt, France) according to the manufacturer’s protocol. 
Then, 1 µg of RNA was reverse-transcribed, and quantitative 
real-time PCR reactions were run using SYBR Green Supermix 
on an iCycler iQ multicolor detection system (Bio-Rad) as 
previously described (Monniaux  et  al. 2008). The specific 
primer sequences used for amplification are listed in Table 1. 
For each primer pair, amplification efficiency (E) was measured 
as described (Monniaux  et  al. 2008). The cycle threshold 
(Ct) of the target gene was compared with that of the RPL19 
internal reference gene encoding a ubiquitous ribosomal 
protein, and the mRNA relative level was estimated by the 
ratio R = 100 × (ERPL19
Ct (RPL19)/Etarget
Ct (target)). RPL19 is known to 
be easily detectable and not regulated during ovine follicular 
growth (Bonnet et al. 2011), and it has been used and validated 
as a reference gene in the granulosa cells of sheep follicles in 
previous studies (Drouilhet et al. 2013, Estienne et al. 2015, 
Pierre et al. 2016).
Inhibin and activin assays
Inhibin A concentration in follicular fluid was measured 
using the Active Inhibin A ELISA kit (Beckman Coulter France) 
according to the manufacturer’s protocol. The use of the Active 
Inhibin A ELISA kit in sheep has been validated by studying 
serial dilutions of different ovine plasma and follicular fluid 
samples in steer plasma. Results showed that the dilution curves 
were linear and parallel to the standard curve (Supplementary 
Fig. 1A, see section on supplementary data given at the end 
of this article). In the present study, inhibin A concentrations 
were determined in 30 µL aliquots of follicular fluid diluted 
at 1/100 and 1/1000 for small and large follicles respectively. 
In our working conditions, the limit of detection of the assay 
was found to be 0.5 pg/well and the intra- and inter-assays 
coefficients of variation were lower than 5%.
Activin A concentration in follicular fluid was measured 
using the Human/Mouse/Rat Activin A Quantikine ELISA kit 
(R&D Systems Europe) according to the manufacturer’s protocol. 
The use of the Human/Mouse/Rat Activin A Quantikine ELISA 
kit in sheep has been validated by studying serial dilutions 
of different ovine plasma and follicular fluid samples in steer 
plasma. Results showed that the dilution curves were linear 
and parallel to the standard curve (Supplementary Fig. 1B). In 
the present study, Activin A concentrations were determined 
in 100 µL aliquots of follicular fluid diluted at 1/1000 and 
1/10,000 for small and large follicles respectively. In our 
working conditions, the limit of detection of the assay was found 
to be 1.5 pg/well, and the intra- and inter-assays coefficients of 
variation were lower than 5% and 7% respectively.
Statistical analysis
All data are presented as mean ± s.e.m. Data were analyzed 
using the GraphPad Prism 6 Software (GraphPad Software). In 
the wild-type (+/+) ewes, comparisons of follicle numbers and 
sizes between the Rasa Aragonesa and the Grivette breeds were 
made using Mann–Whitney test, and comparisons of gene 
expression and hormonal concentrations in follicular fluid 
between breeds and follicular size classes were made using 
Table 1 Quantitative PCR primers sequences and their efficiency.
Gene accession number Forward sequence 5′→3′ Reverse sequence 5′→3′ efficiency
CYP19A1 NM_001123000.1 TCATCCTGGTCACCCTTCTG CCAGACGAGACCAGCGACCG 1.95
IGFBP5 NM_001129733.1 CTACAAGAGAAAGCAGTG CAGCTTCATCCCATACTT 1.99
INHA NM_001308579.1 GACCAAGATGTCTCCCAG CAGTATGGAACCACAGCT 2.00
INHBA NM_001009458.1 GAAGAGGAAAGAAGAGGAA GTAGTGGTTGATGACTGT 2.08
ACVR1B XM_012174234.2 TTGTGTACTGGGAGATTG ACTAGGTCATAATATGGCAG 1.96
ACVR2A NM_001009293.1 GATTAGTCCTGTGGGAAC GTCTTCAAGAGAGGGATG 2.05
FST NM_001257093.1 TGGACCAGACTAATAATG TATCTTCACAGGACTTTG 1.87
TGFβR3 XM_012176015.2 CTCTTTCTCCAGTGTGAG GATCATTGAGGCATCCAG 1.98
RPL19 XM_004012837 AATGCCAATGCCAACTC CCCTTTCGCTACCTATACC 1.95
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two-way ANOVA. Within each ovine breed, gene expression 
and hormonal concentrations were compared between 
follicular classes and genotypes using two-way ANOVA. The 
ANOVA analyses were followed by Fisher’s protected least 
significant difference (LSD) test for multiple comparisons. For 
granulosa cell culture experiments, data were analyzed using 
repeated measures one-way ANOVA with the Greenhouse–
Geisser correction of the degrees of freedom. For all analyses, 
a probability of at least 0.05 was required for significance.
Results
Follicular development in the Rasa Aragonesa and 
Grivette breeds and effects of BMP15 mutations
There was no difference between the Rasa Aragonesa 
and Grivette breeds for the numbers and sizes of 
follicles present in the ovaries of the wild-type (+/+) 
ewes, but follicular development was affected by the 
presence of BMP15 mutations in both breeds. In the 
Rasa Aragonesa breed, the number of large dominant 
follicles (larger than or equal to 5 mm in the follicular 
phase of the estrous cycle) was higher in the prolific 
R/+ than in the non-prolific +/+ ewes (P < 0.05), and 
the mean size of these large follicles was smaller 
(P < 0.01, Table 2). In the Grivette breed, the number 
of large follicles was not statistically different between 
genotypes, although the mean size of the large follicles 
was smaller in the prolific Gr/Gr ewes than that in 
the +/+ ewes (P < 0.001, Table  2). In both breeds, 
the number of small (1–3 mm) follicles was similar 
between genotypes.
In +/+ ewes, there was no difference between the 
Rasa Aragonesa and Grivette breeds for CYP19A1 (a 
marker of follicle maturation) and IGFBP5 (a marker 
of follicle atresia) expression in granulosa cells. As 
expected, in both breeds and all genotypes, CYP19A1 
mRNA levels were strongly increased in the granulosa 
cells of the large follicles, compared to those in the 
small ones (P < 0.001 for all comparisons, Fig.  1). 
This increase in granulosa cell differentiation was 
associated with a lower expression of the atresia 
marker IGFBP5 in the large follicles (Rasa Aragonesa 
breed: P < 0.001 for both +/+ and R/+ follicles; Grivette 
breed: P < 0.05 for +/+ follicles and P < 0.01 for Gr/Gr 
follicles). There was no difference between genotypes, 
except a 1.9-fold lower CYP19A1 expression in R/+ 
than that in +/+ large follicles, in the Rasa Aragonesa 
breed (P < 0.05, Fig. 1).
Ovarian expression of inhibin A and activin A in the 
Rasa Aragonesa and Grivette breeds and effects of 
BMP15 mutations
The mRNA levels of INHA and INHBA were higher 
(P < 0.001 for both genes) in +/+ granulosa cells from 
large follicles of the Grivette, compared to the Rasa 
Aragonesa breed. In both breeds and all genotypes, 
INHA and INHBA mRNA levels were strongly increased 
in the granulosa cells of the large follicles, compared 
Table 2 Follicular populations in the ovaries of Rasa Aragonesa and Grivette ewes with different genotypes.
Breed Rasa aragonesa Grivette
Genotype (No. of ewes) +/+ (n = 6) R/+ (n = 6) +/+ (n = 5) Gr/Gr (n = 5)
No. of small follicles (1–3 mm) 43.0 ± 7.4 42.8 ± 6.5 48.2 ± 3.7 56.6 ± 6.8
No. of large follicles (larger than or equal to 5 mm) 2.3 ± 0.3 3.7 ± 0.3* 2.2 ± 0.2 3.8 ± 0.9
Mean diameter of the large follicles (mm) 7.25 ± 0.33 5.88 ± 0.11** 7.06 ± 0.28 5.36 ± 0.09***
*P < 0.05, **P < 0.01, ***P < 0.001 vs +/+ ewes of the same breed.
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Figure 1 Consequences of the presence of natural loss-of-function 
mutations in the BMP15 gene on the expression of functional gene 
markers in the granulosa cells of ewes. Results represent CYP19A1 
(a marker of fully differentiated granulosa cells, upper panels) and 
IGFBP5 (a marker of apoptotic granulosa cells, lower panels) 
expression in small growing (1–3 mm) and large dominant (larger 
than or equal to 5 mm) follicles from +/+ (n = 6, black bars) and  
R/+ (n = 6, open bars) Rasa Aragonesa ewes (left panels), and +/+ 
(n = 5, black bars) and Gr/Gr (n = 5, open bars) Grivette ewes (right 
panels). All the follicles were recovered on the ovaries of ewes in the 
follicular phase of a synchronized estrous cycle. CYP19A1 and 
IGFBP5 mRNA accumulation was studied by reverse transcription 
and quantitative PCR and represented as mRNA relative level, using 
RPL19 as an internal reference. In each panel, data were analyzed by 
two-way ANOVA, and different letters indicate significant differences 
(P < 0.05) between follicular classes and genotypes.
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to the small ones (P < 0.001 for both genes and all 
comparisons, Fig. 2). Within each breed, there was no 
difference between genotypes for INHA and INHBA 
mRNA levels.
The intra-follicular concentrations of inhibin A and 
activin A were both higher (P < 0.001 and P < 0.01 
respectively) in +/+ large follicles of the Grivette, 
compared to those in the Rasa Aragonesa breed, but 
the activin A/inhibin A concentration ratio was similar 
between breeds. In both breeds and all genotypes, 
the intra-follicular concentrations of inhibin A were 
higher in the large follicles, compared to those in the 
small ones (P < 0.001 for all comparisons) and, except 
for the Rasa Aragonesa +/+ ewes, the intra-follicular 
concentrations of activin A were also significantly 
higher in the large follicles (P < 0.05 for all comparisons, 
Fig.  3). In both breeds and all genotypes, the activin 
A/inhibin A concentration ratio was lower in the large 
follicles, compared to that in the small ones (P < 0.001 
for all comparisons). No significant differences were 
found between genotypes, except a 2.3-fold higher 
concentration of inhibin A in R/+, compared to +/+ large 
follicles, in the Rasa Aragonesa breed (P < 0.05, Fig. 3).
Ovarian expression of activin receptors and activin/
inhibin-binding proteins in the Rasa Aragonesa and 
Grivette breeds and effects of BMP15 mutations
The mRNA levels of ACVR1B and ACVR2A were higher 
in +/+ granulosa cells from large follicles (P < 0.001 for 
both genes) and small follicles (P < 0.05 and P < 0.001 
R
el
at
iv
e 
m
RN
A 
le
v
el
s 
R
el
at
iv
e 
m
RN
A 
le
v
el
s 
R
el
at
iv
e 
m
RN
A 
le
v
el
s 
R
el
at
iv
e 
m
RN
A 
le
v
el
s 
Figure 2 Consequences of the presence of natural loss-of-function 
mutations in the BMP15 gene on the expression of genes encoding 
inhibin A and activin A subunits in the granulosa cells of ewes. 
Results represent INHA (upper panels) and INHBA (lower panels) 
expression in small growing (1–3 mm) and large dominant (larger 
than or equal to 5 mm) follicles from +/+ (n = 6, black bars) and  
R/+ (n = 6, open bars) Rasa Aragonesa ewes (left panels), and +/+ 
(n = 5, black bars) and Gr/Gr (n = 5, open bars) Grivette ewes (right 
panels), analyzed as described in Fig. 1. In each panel, different 
letters indicate significant differences (P < 0.05) between follicular 
classes and genotypes. ***P < 0.001 vs the corresponding follicle 
class in +/+ Rasa Aragonesa ewes.
Figure 3 Consequences of the presence of natural loss-of-function 
mutations in the BMP15 gene on the intra-follicular concentration of 
inhibin A and activin A in sheep ovaries. Results represent the 
concentrations of inhibin A (upper panels), activin A (middle panels) 
and the activin A/inhibin A concentration ratio (lower panels) in 
small growing (1–3 mm) and large dominant (larger than or equal to 
5 mm) follicles from +/+ (n = 6, black bars) and R/+ (n = 6, open bars) 
Rasa Aragonesa ewes (left panels) and +/+ (n = 5, black bars) and 
Gr/Gr (n = 5, open bars) Grivette ewes (right panels). Follicular fluids 
were recovered on the ovaries of ewes in the follicular phase of a 
synchronized estrous cycle, and hormonal concentrations were 
measured by ELISA. In each panel, data were analyzed by two-way 
ANOVA and different letters indicate significant differences (P < 0.05) 
between follicular classes and genotypes. **P < 0.01, ***P < 0.001 vs 
the corresponding follicle class in +/+ Rasa Aragonesa ewes.
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for ACVR1B and ACVR2A respectively) of the Grivette, 
compared to the Rasa Aragonesa breed. In the Grivette 
breed, ACVR1B and ACVR2A mRNA levels were higher 
in the granulosa cells of the large follicles, compared 
to the small ones for both genotypes (ACVR1B and 
ACVR2A: P < 0.001 for +/+ follicles and P < 0.05 for 
Gr/Gr follicles, Fig.  4), but there was no significant 
difference between follicular sizes in the Rasa Aragonesa 
breed, except higher ACVR2A mRNA levels in the large 
R/+ follicles, compared to the small ones of the same 
genotype (P < 0.01). In the Grivette breed, ACVR1B 
mRNA levels were 1.9-fold lower (P < 0.01) and 
ACVR2A mRNA levels were 1.6-fold lower (P < 0.01) in 
Gr/Gr, compared to +/+ large follicles (Fig. 4), but no 
difference between genotypes was observed in the Rasa 
Aragonesa breed.
The mRNA levels of FST and TGFBR3 were lower 
(P < 0.05 and P < 0.01 respectively) in +/+ granulosa 
cells from large follicles of the Grivette, compared to the 
Rasa Aragonesa breed. In both breeds and all genotypes, 
FST and TGFBR3 mRNA levels were increased in the 
granulosa cells of the large follicles, compared to the 
small ones (FST: P < 0.001 for both breeds and all 
genotypes, TGFBR3: P < 0.001 for both genotypes in 
Rasa Aragonesa breed, P < 0.001 for +/+ and P < 0.01 
for Gr/Gr genotypes in Grivette breed, Fig.  5). FST 
mRNA levels were 1.6-fold lower (P < 0.05) in R/+, 
compared to +/+ small follicles in the Rasa Aragonesa 
breed (Fig. 5), but no difference in FST expression was 
observed between genotypes in the Grivette breed. 
TGFBR3 mRNA levels were 1.4-fold lower (P < 0.05) in 
Gr/Gr, compared to +/+ large follicles in the Grivette 
breed (Fig. 5), but no difference between genotypes was 
observed in the Rasa Aragonesa breed.
Regulation of the components of the inhibin/activin 
system by BMP15 and activin A in ovine granulosa cells 
in vitro
The small (<3-fold changes), or non-existent differences 
observed between genotypes and the inconsistency 
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Figure 4 Consequences of the presence of natural loss-of-function 
mutations in the BMP15 gene on the expression of genes encoding 
activin receptors in the granulosa cells of ewes. Results represent 
ACVR1B (upper panels) and ACVR2A (lower panels) expression in 
small growing (1–3 mm) and large dominant (larger than or equal to 
5 mm) follicles from +/+ (n = 6, black bars) and R/+ (n = 6, open bars) 
Rasa Aragonesa ewes (left panels) and +/+ (n = 5, black bars) and 
Gr/Gr (n = 5, open bars) Grivette ewes (right panels), analyzed as 
described in Fig. 1. In each panel, different letters indicate significant 
differences (P < 0.05) between follicular classes and genotypes. 
*P < 0.05, ***P < 0.001 vs the corresponding follicle class in +/+ 
Rasa Aragonesa ewes.
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Figure 5 Consequences of the presence of natural loss-of-function 
mutations in the BMP15 gene on the expression of genes encoding 
activin/inhibin-binding proteins in the granulosa cells of ewes. 
Results represent FST (encoding follistatin, the specific activin-
binding protein, upper panels) and TGFBR3 (encoding betaglycan, 
the co-receptor of inhibin, lower panels) expression in small growing 
(1–3 mm) and large dominant (larger than or equal to 5 mm) follicles 
from +/+ (n = 6, black bars) and R/+ (n = 6, open bars) Rasa Aragonesa 
ewes (left panels), and +/+ (n = 5, black bars) and Gr/Gr (n = 5, open 
bars) Grivette ewes (right panels), analyzed as described in Fig. 1. 
In each panel, different letters indicate significant differences 
(P < 0.05) between follicular classes and genotypes. 
*P < 0.05, **P < 0.01 vs the corresponding follicle class in +/+ 
Rasa Aragonesa ewes.
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of the changes found associated with the presence of 
BMP15 mutations between breeds led us to investigate 
whether the components of the inhibin/activin system 
could be direct target genes of BMP15. As BMP15 is 
known to act alone or in interaction with GDF9, and thus 
activate different SMAD signaling pathways involved 
in BMP or/and activin signaling (Mottershead  et  al. 
2015), the effects of BMP15 and GDF9, acting alone 
or in combination, were compared with those of BMP4 
(a canonical inducer of the BMP signaling pathway) 
and Activin A (Fig.  6). In 48 h-culture experiments in 
serum-free conditions, BMP4 and BMP15 enhanced 
INHBA (P < 0.001 and P < 0.01 respectively) and FST 
(both P < 0.001) expression, but inhibited TGFBR3 (both 
P < 0.001) expression and had no significant effect on 
INHA, ACVR1B and ACVR2A mRNA levels. Similarly, 
Activin A enhanced FST (P < 0.01) and reduced TGFBR3 
(P < 0.01) expression and had no effect on ACVR1B 
expression; in addition, Activin A enhanced INHA 
(P < 0.01) expression and, unlike BMPs, had no effect on 
INHBA mRNA levels but inhibited ACVR2A (P < 0.01) 
expression. GDF9 alone had no effect on the mRNA 
levels of all studied genes. However, the combination 
of BMP15 and GDF9 slightly reduced BMP15 effects 
on INHBA (P < 0.05) expression, but enhanced BMP15 
effects on FST (P < 0.05) and INHA (P < 0.05) expression.
Discussion
To our knowledge, this is the first study dedicated to the 
regulation by BMP15 of the ovarian expression of the 
whole inhibin/activin system, i.e. inhibin and activin 
subunits, activin receptors and antagonists, based on 
complementary investigations in vitro and in vivo. We 
have identified the direct target genes of BMP15 among 
these components and evaluated the consequence of 
the presence of BMP15 loss-of-function mutations on 
their ovarian expression in two different genetic models 
of hyperprolific sheep.
In vitro, the effects of BMP15, BMP4 and activin 
A itself were compared on the expression of the 
different components of the inhibin/activin system. 
In ovine granulosa cells recovered from small antral 
follicles, BMP15 (acting alone or in combination with 
GDF9), BMP4 and activin A all enhanced FST and, 
in a lesser extent, INHA expression, but inhibited the 
expression of TGFBR3. In addition, INHBA expression 
was specifically enhanced by BMP15 and BMP4, 
Figure 6 Effect of BMP4, BMP15, GDF9 and 
activin A on the expression of genes encoding 
different members of the inhibin/activin system 
in ovine granulosa cells. Sheep granulosa cells 
were cultured in 96-well plates for 48 h with 
or without 50 ng/mL of the different factors. 
Each treatment was tested in 12 replicate 
wells, then cells were pooled according to 
treatment at the end of culture for mRNA 
preparation. Messenger RNA accumulation of 
INHA, INHBA, ACVR1B, ACVR2A, FST and 
TGFBR3 was studied by reverse transcription 
and quantitative PCR relatively to RPL19 as 
internal reference. The results were expressed 
in percentage of expression relatively to that of 
cells cultured without ligand (Ctrl, fixed at 
100%). Data represent the results of 15 
independent experiments performed for each 
treatment. Comparisons of means between 
different treatments were made by repeated 
measures one-way ANOVA with the 
Greenhouse–Geisser correction of the degrees 
of freedom, followed by Fisher’s LSD test for 
multiple comparisons. (*)P < 0.1, *P < 0.05, 
**P < 0.01, ***P < 0.001 vs Ctrl, or between 
BMP15 and BMP15 + GDF9 conditions.
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whereas ACVR2A expression was inhibited by activin A 
only. The similar effects of BMP4 and BMP15 can be 
explained by their common activation of the SMAD1/5/8 
signaling pathway (Moore et al. 2003), whereas GDF9 
and activin A are known to signal through SMAD2/3 
proteins (Mazerbourg et al. 2004). From our results, no 
effect of GDF9 alone was observed, in agreement with 
the presence of a low activation level of the SMAD2/3 
signaling pathway by GDF9 in ovine granulosa cells 
(Pierre  et  al. 2016). However, GDF9 was found to 
enhance and decrease the stimulating effects of BMP15 
on the expression of FST and INHBA respectively. GDF9 
and BMP15 are known to form heterodimers (Liao et al. 
2003, McIntosh  et  al. 2008) and exhibit synergistic 
interactions by activating both SMAD pathways 
(Mottershead  et  al. 2015). These interactions might be 
involved in the observed regulations by BMP15 and 
GDF9, when acting together.
In vivo, the FecXR mutation, when present at the 
heterozygous state in the Spanish Rasa Aragonesa 
breed, was associated with a 1.9-fold increase in 
ovulation rate, compared to the ovulation rate of non-
carrier ewes of the same breed, whereas the recently 
discovered FecXGr mutation, when present at the 
homozygous state in the French Grivette breed, led to 
a 2.1-fold increase in ovulation rate, in agreement with 
previous observations (Lahoz et al. 2011, Demars et al. 
2013). From our results, compared to non-carrier ewes, 
BMP15 mutant ewes exhibited a higher number of large 
dominant (preovulatory) follicles during the follicular 
phase of the estrous cycle, associated with a small 
decrease in their diameter, suggesting an earlier final 
differentiation of their granulosa cells, as previously 
proposed for the Inverdale ewes carrying the FecXI 
mutation in BMP15 (McNatty  et  al. 2009) and more 
strikingly for the Booroola ewes carrying the FecBB 
mutation in BMPR1B (Henderson et al. 1985). However, 
there was no clear effect of the FecXR and the FecXGr 
mutations on CYP19A1 mRNA levels in the granulosa 
cells recovered from the two studied follicular size 
classes, i.e. small (1–3 mm) and large (less than or 
equal to 5 mm) follicles. It is possible that the choice of 
these follicular classes did not allow detecting any fine 
difference in the maturation stage of the granulosa cells 
between genotypes. However, the intermediary class of 
3–5 mm follicles was discarded from analysis, due to the 
high expression of IGFBP5 and other markers of atresia 
or apoptosis (Supplementary Fig. 2 and Supplementary 
Table  1) in this size class containing the subordinate 
follicles already engaged in the atresia process.
The presence of loss-of-function BMP15 mutations 
in vivo had little effect on the expression of the components 
of the inhibin/activin system and the differences found 
between genotypes were not consistent with the effects 
of BMP15 observed on ovine granulosa cells in vitro. For 
instance, the expression of INHA, INHBA and FST was 
not, or only slightly, affected by the presence of BMP15 
mutations in vivo in both breeds, despite the existence 
of a stimulating effect of BMP15 on the expression of 
these genes in vitro. From our in vitro results, activin A 
was able to enhance the expression of INHA and FST 
expression and could such participate in balancing the 
expression level of these components in vivo. However, 
this hypothesis cannot explain why INHBA was 
unaffected by the presence of BMP15 mutations in vivo.
The components of the inhibin/activin system 
were affected by the presence of a loss-of-function 
BMP15 mutation differently in the Rasa Aragonesa 
and the Grivette breed. For example, in the granulosa 
cells of the large follicles, ACVR1B, ACVR2A and 
TGFBR3 mRNA levels were lower in the homozygous 
FecXGr, compared to non-carrier Grivette ewes, but 
such differences were not observed between the 
heterozygous FecXR and non-carrier Rasa Aragonesa 
ewes. Other examples of discrepancies could be 
cited, concerning inhibin A concentrations in large 
follicles and FST expression in the granulosa cells of 
small follicles. These discrepancies might be related to 
the mutation itself or its homozygous or heterozygous 
state. The FecXR mutation is known to preclude BMP15 
production (Martinez-Royo et al. 2008), and the FecXGr 
mutation totally impairs BMP15 signaling in target cells 
(Demars et al. 2013). In both models, a lowering of the 
biological activity of BMP15 is expected, due to lower 
amounts of the mature protein (as hypothesized in 
R/+ follicles) or lower functional interactions between 
BMP15 and GDF9 (as hypothesized in Gr/Gr follicles), 
but the molecular mechanisms affecting BMP15 are not 
yet fully understood. Alternatively, the in vivo expression 
level of each component of the inhibin/activin system 
could depend on the specific equilibrium of the different 
components existing within each breed. This hypothesis 
is supported by the observation that the granulosa cells 
of non-mutant Grivette ewes expressed higher levels of 
INHA, INHBA, ACVR1B and ACVR2A, but lower levels 
of FST and TGFBR3 mRNA than the granulosa cells of 
non-mutant Rasa Aragonesa ewes. Consistently, the 
concentrations of activin A and inhibin A proteins were 
higher in the follicles of Grivette ewes, also illustrating 
pre-existing differences in the inhibin/activin system 
between breeds, in the absence of BMP15 mutation.
The complexity of the inhibin/activin system may 
explain that (1) the effects of BMP15 on granulosa 
cells in vitro are not consistent with the expressional 
changes observed when a loss-of-function BMP15 
mutation is present in vivo; (2) the consequences of a 
BMP15 mutation differ between breeds. Activin A and 
its receptors are positive elements of activin signaling, 
whereas inhibin, follistatin and the inhibin co-receptor 
called TGFBR3 (or betaglycan) are antagonistic elements. 
From our in vitro results, BMP15 and activin A itself can 
acutely regulate the expression of both positive and 
negative components of the inhibin/activin system. We 
propose that a re-balancing of the components of this 
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system in vivo can explain the small effects of BMP15 
loss-of-function mutations and the inconsistency of the 
changes found associated with the presence of BMP15 
mutations in different genetic backgrounds. Therefore, 
the inhibin/activin system would not be implicated in 
the mechanisms leading to multiple ovulations in ewes 
carrying BMP15 mutations, in contrast to the recently 
evidenced AMH system (Pierre et al. 2016).
In conclusion, the presence of a loss-of-function 
BMP15 mutation, such as the FecXR mutation when 
present at the heterozygous state, or the FecXGr mutation 
when present at the homozygous state, is associated 
with a clear increase in ovulation rate leading to a 
higher prolificacy. In this study, we have challenged a 
potential role of the ovarian inhibin/activin system in 
participating in this phenotype. From our in vitro results, 
the genes encoding different components of the inhibin/
activin system such as INHA, INHBA, FST and TGFBR3 
are potential targets of BMP15 in ovine granulosa cells. 
However, in vivo, the presence of a loss-of-function 
BMP15 mutation in ewes was not found associated with 
strong changes in the expression of these components 
in granulosa cells. Moreover, the observed expressional 
changes were dependent on either the BMP15 mutation 
itself or the ovine breed in which the mutation was 
present. Altogether, these results suggest that the ovarian 
inhibin/activin system is not a key component of the 
mechanisms regulating the ovulation rate in BMP15 
mutant ewes.
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